Synowledge is a global provider of drug safety, regulatory affairs and related IT solutions to small, mid and large sized pharmaceutical and biotechnology companies.
Online PR News – 28-May-2012 – Stamford – Stamford, CT, May 22, 2012 - Synowledge, a market leader known for its global and progressive approach to providing drug safety, regulatory affairs and related IT solutions to life sciences organizations, is pleased to announce that it will be showcasing its comprehensive suite of services at the upcoming 48th Drug Information Association (DIA) Annual Meeting in Philadelphia, PA on June 24-28, 2012.
The Annual Meeting is DIA’s flagship North American conference. With over 7,000 attendees from over 80 countries, it provides an invaluable forum for professionals involved with all aspects of health care product development.
Synowledge will be exhibiting at the conference, where it will present its complete line of life sciences services. Attendees are encouraged to visit booth #2100 to learn more about Synowledge’s unique set of custom-tailored outsourcing solutions designed to meet the specific needs of life sciences organizations worldwide.
To schedule a meeting with a Synowledge representative at the 2012 DIA Annual Meeting, please contact Han Broekmeijer at +1 (203) 504-2561 or by email at email@example.com.
For more information about the 48th Annual DIA Annual Meeting, please visit: http://www.diahome.org/Flagship-Meetings/DIA2012.aspx
Synowledge is a global provider of drug safety, regulatory affairs and related IT solutions to small, mid and large sized pharmaceutical and biotechnology companies. Our comprehensive outsourcing solutions combine the unique strengths of both onshore and offshore services to meet our clients’ needs. With more than 15 years of industry experience, our core team members have worked with leading pharmaceutical, biotech, medical device, and health care provider organizations. Synowledge is headquartered in Stamford, CT, USA with operation facilities located in Ohio, the United Kingdom, Germany, and India. For more information, please visit www.synowledge.com.